Approval · Notice of Compliance 1699 · 2001
AMSA PD: Notice of Compliance 1699
Issued January 18, 2001
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 1699
- Date
- January 18, 2001
- Company
- Pfizer Canada UlcKirkland, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Manufacturer name change
- Therapeutic class
- Antineoplastic agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| AMSA PD | 00582212 | Cancelled Post Market |
Medicinal ingredients
- AMSACRINE 50 MG per ML